Jan Kalinovsky

Jan Kalinovsky currently serves as Medical Director, Oncology at ICON plc, a position held since October 2020. Prior experience includes roles such as Clinical Research Scientist at Novocure, where responsibilities involved serving as a medical expert for cancer-related studies, and Global Medical Lead, Oncology at Bayer Pharmaceuticals, overseeing data generation and medical planning for Phase II-IV studies. Jan also held the Country Medical Director position at Bayer, coordinating medical activities at the country level. Earlier roles include Study Medical Expert for SOTIO a.s., focused on immuno-oncology products, and Medical Advisor at Pfizer, providing medical support for market access and clinical programs. Jan holds a Doctor of Medicine degree from Charles University and completed a Radiation Oncology Residency at IPVZ Praha.